The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 31, 2017

Filed:

Mar. 02, 2015
Applicant:

Aviva Biosciences Corporation, San Diego, CA (US);

Inventors:

Ping Lin, San Diego, CA (US);

Douglas T. Yamanishi, Huntington Beach, CA (US);

George Walker, San Diego, CA (US);

Junquan Xu, San Diego, CA (US);

Mingxian Huang, San Diego, CA (US);

Guoliang Tao, San Diego, CA (US);

Lei Wu, San Diego, CA (US);

Xiaobo Wang, San Diego, CA (US);

Joe Ouyang, San Diego, CA (US);

Jing Cheng, Beijing, CN;

Jia Xu, Washington, DC (US);

Assignee:

AVIVA BIOSCIENCES CORPORATION, San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2006.01); A61M 1/36 (2006.01); B01D 57/02 (2006.01); B01D 61/18 (2006.01); B01D 67/00 (2006.01); B01D 71/02 (2006.01); B01D 71/04 (2006.01); B01L 3/00 (2006.01); G01N 1/40 (2006.01); G01N 15/02 (2006.01); G01N 15/05 (2006.01); G01N 33/569 (2006.01); G01N 33/574 (2006.01); G01N 1/34 (2006.01); G01N 15/00 (2006.01); G01N 15/06 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6881 (2013.01); A61M 1/36 (2013.01); A61M 1/362 (2014.02); A61M 1/3618 (2014.02); A61M 1/3679 (2013.01); B01D 57/02 (2013.01); B01D 61/18 (2013.01); B01D 67/0034 (2013.01); B01D 67/0062 (2013.01); B01D 71/02 (2013.01); B01D 71/027 (2013.01); B01D 71/04 (2013.01); B01L 3/502 (2013.01); B01L 3/502753 (2013.01); B01L 3/502761 (2013.01); G01N 1/34 (2013.01); G01N 1/40 (2013.01); G01N 1/4077 (2013.01); G01N 15/0272 (2013.01); G01N 15/05 (2013.01); G01N 33/56966 (2013.01); G01N 33/57407 (2013.01); B01D 2325/021 (2013.01); B01L 3/5027 (2013.01); B01L 2300/0681 (2013.01); B01L 2300/0816 (2013.01); B01L 2300/0861 (2013.01); B01L 2400/0409 (2013.01); B01L 2400/0457 (2013.01); B01L 2400/0478 (2013.01); B01L 2400/065 (2013.01); B01L 2400/0644 (2013.01); G01N 2001/4016 (2013.01); G01N 2015/0073 (2013.01); G01N 2015/0288 (2013.01); G01N 2015/0294 (2013.01); G01N 2015/0681 (2013.01); G01N 2333/4724 (2013.01); Y10T 436/25375 (2015.01);
Abstract

The present invention recognizes that diagnosis and prognosis of many conditions can depend on the enrichment of rare cells, especially tumor cells, from a complex fluid sample such as a blood sample. In particular, the present invention is directed to methods and compositions for detecting a non-hematopoietic cell, e.g., a non-hematopoietic tumor cell, in a blood sample via, inter alia, removing red blood cells (RBCs) from a blood sample using a non-centrifugation procedure, removing white blood cells (WBCs) from said blood sample to enrich a non-hematopoietic cell, if any, from said blood sample; and assessing the presence, absence and/or amount of said enriched non-hematopoietic cell.


Find Patent Forward Citations

Loading…